OmniTrace Locates Patients Lost to Follow-Up
Call Us: (800) 799-1911 or Complete Our Form:
OmniTrace - The Lost to Follow-Up Search Experts
OmniTrace Corp. was founded in 2001 and has since developed into a global provider of Lost to Follow-Up clinical trial support services. OmniTrace provides our services to a global clientele of clinical trial sponsors, contract research organizations, academic institutions, National Institutes of Health, study sites and hospitals.
Our nationwide network of researchers, investigators and genealogists, combined with a sophisticated computer and database system, allows us to locate patients anywhere in the world.
Benefits of a Lost to Follow-Up program:
- Virtually eliminates the issue of LTFU patients
- Maximizes clinical trial success
- Determine vital status of all withdrawn patients
- Helps maintain clinical trial integrity
- Allows a faster clinical trial endpoint
- Enhances regulatory compliance and post study surveillance
- Greatly reduces clinical trial costs
OmniTrace will customize our patient locate program to your requirements.
The OmniTrace Solution – A Comprehensive Approach to Locating Missing Patients in Clinical Trials
At OmniTrace Corp., we understand the challenges that CROs, pharmaceutical companies, and clinical trial investigators face when patients go missing during a clinical trial. That’s why we provide a comprehensive solution to mitigate the risks associated with patient lost-to-follow-up. Our dedicated team of experienced investigators uses innovative techniques and cutting-edge technology to locate missing clinical trial patients worldwide.
OmniTrace Highlights
- CENTAUR Trial - The Vital Status of all but One Randomized Participant was Successfully Confirmed.
- TRAVERSE Study
- Takeda CARES
- Developing a Statewide Clinical Trial Registry for Georgia Residents – Georgia Public Policy Foundation
- Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout | NEJM
Frequently Asked Questions
- Significantly reduce the number of LTFU patients
- Determine vital status of those who have withdrawn
- Monitor Major Adverse Events
- Reduce FDA scrutiny
- Maximize clinical trial success
- Eliminate missing trial data
- Allow for a faster clinical trial endpoint
- Enhance regulatory compliance and post study surveillance
- Reduce clinical trial cost
OmniTrace conducts research of publicly available records and databases to identify current contact information or vital status data on subjects who are Lost to Follow-Up or have withdrawn consent. This simple, crucial function significantly reduces missing data that may bias in study results and hinder the regulatory process.
OmniTrace’s services are available in over fifty countries.
OmniTrace provides comprehensive project support including ICF language review, LTM/CRA/Site LTFU training, IRB and EC response and rebuttals, death certificate retrieval, MAE monitoring, EDC assistance, Site communication, metrics development as well as other custom services.
OmniTrace’s clients consist of Pharmaceutical Companies, CROs, AROs, Hospitals, clinical trial sites and government agencies such as the National Institutes of Health.
For USA searches average turnaround time is 24 – 48 hours. Global searches will vary by country and may range from 7-21 days.
OmniTrace conducts legal and permissible research of publicly available records and databases where local regulations allow and when appropriate patient consent has been obtained.
Case Studies
- A large pharmaceutical company conducted a randomized, open label, blinded-endpoint parallel group study to investigate if a particular drug has a lower incident of GI Events than other similar drugs in subjects with osteoarthritis. Goal: Retrieve patient contact information from each site, locate the current contact information and return information to the site. Total LTFU Subjects: 443 Number of Sites: 208 Result: OmniTrace was successful in locating 91% of all LTFU patients.
- A medium sized pharmaceutical firm conducted a 56 week phase III trial to access the safety and efficiency of an obesity treatment program. Goal: Retrieve patient contact information from each site, locate the current contact information and return it to the site. If a patient was deceased we were to provide their date of death and the resource of such data. Additionally, we were to attempt to obtain a death certificate for each subject. If the subject was alive, we were to provide the most recent “alive as of” date. Total Subjects: 416 Number of sites: 87 Result: OmniTrace successfully determined the vital status for 99% of the subjects provided.
- A leading university research hospital conducted a small endocrinology study across a limited group of subjects. Goal: Work directly with hospital study coordinator to receive patient information, update the information and return directly to the coordinator. Total Subjects: 47 Results: OmniTrace successfully located 44 of the 47 subjects.
- A large European based pharmaceutical firm conducted a parallel, randomized, controlled evaluation cardiovascular study in 27 countries. Goal: Retrieve subject information directly from the sites and conduct a vital status search for each subject. Total Subjects: 47 Number of Sites: 21 Result: OmniTrace successfully determined the vital status for 92% of subjects.
LTFU About Us:
The OmniTrace Solution – A Comprehensive Approach to Locating Missing Patients in Clinical Trials:
At OmniTrace Corp., we understand the challenges that CROs, pharmaceutical companies and clinical trial investigators face when patients go missing during a clinical trial. That’s why we provide a comprehensive solution to mitigate the risks associated with patient lost-to-follow-up. Our dedicated team of experienced investigators uses innovative techniques and cutting-edge technology to locate missing clinical trial patients worldwide.
The Problem of Missing Patients in Clinical Trials:
Missing patients pose a significant problem in the clinical trial industry, leading to costly delays, impacting the validity and reliability of study results and adding additional expenses to the study’s budget. Some reasons for missing patients include relocation, lack of transportation, and lack of engagement.
The OmniTrace Solution:
Our approach is fully compliant with data protection regulations and integrates seamlessly with existing clinical trial workflows. We conduct investigations to locate missing patients and communicate our findings to the study sites.
The Benefits of the OmniTrace Solution:
By addressing the issue of patient lost-to-follow-up early in the trial process, our solution helps improve patient retention rates, reduce costly delays, and ensure that your study is completed on time, within budget, and with accurate data.
Conclusion:
Locating missing patients is critical for the success of a clinical trial. The OmniTrace Solution provides a comprehensive approach to locating missing patients, which helps reduce the number of lost-to-follow-up patients, improve patient retention rates, and increase the chances of a successful trial outcome. Addressing the issue of missing patients will not only improve the quality of clinical trial data but also reduce the cost and time associated with patient recruitment and retention.
At OmniTrace Corp., we provide services worldwide and believe that our solution can significantly benefit CROs and pharmaceutical companies by improving patient retention rates and ensuring that your study is completed on time, within budget, and with accurate data. If you have any questions or would like to discuss our services in more detail, please do not hesitate to contact us.
What Our Clients Are Saying
Looking For An Heir, Lost Patient or Missing Person?
Since 2001, OmniTrace has helped the legal, clinical trial and business communities locate missing people. Known for fast, accurate, and discreet results, OmniTrace is the trusted choice when someone needs to be found.